With the analysis among 30,653 patents, we discovered top 475 key players by total patent application. Boehringer Ingelheim International GmbH, Bristol Myers Squibb Co., Boehringer Ingelheim Pharma GmbH are dominant in this area. They take 13.10% of the total patent filing.
Boehringer Ingelheim International GmbH
Rheinland-Pfalz, Germany
Patent: 1,401
New York, United States
Patent: 1,361
Boehringer Ingelheim Pharma GmbH
Syngenta Participations AG
Basel-Stadt, Switzerland
Patent: 1,181
F. Hoffmann-La Roche Ltd.
California, United States
Patent: 754
Colorado, United States
Patent: 489
Rheinland-Pfalz, Germany
Patent: 481
With the analysis among 367 patents, we discovered top 56 start-ups by total patent application. Shenzhen Tajirui Biomedical Co. Ltd., Institut National de la Santé et de la Recherche Médicale, BUGWORKS Research, Inc. are active in this area.
Shenzhen Tajirui Biomedical Co. Ltd.
Guangdong Sheng, China
Patent: 69
Institut National de la Santé et de la Recherche Médicale
Karnataka, India
Patent: 24
Hangzhou Andao Pharmaceutical Co., Ltd.
Zhejiang Sheng, China
Patent: 23
Sumitomo Dainippon Pharma Oncology, Inc.
ZURICH, Switzerland
Patent: 18
Chengdu Hyperway Pharmaceuticals Co., Ltd.
Sichuan Sheng, China
Patent: 15
TransThera Sciences (Nanjing), Inc.
Jiangsu Sheng, China
Patent: 11
HERTFORD COUNTY, United Kingdom
Patent: 10
With the analysis among related 7,286 patents applied in the last 5 years. We discover 500 most active companies in this area. The fast-growing Bristol Myers Squibb Co., Celgene Corp., Syngenta Crop Protection AG take 11.39% of patent filing during this period.
New York, United States
Patent: 347
New Jersey, United States
Patent: 250
Syngenta Crop Protection AG
undefined undefined
Patent: 233
Basel-Stadt, Switzerland
Patent: 206
Syngenta Participations AG
Sunshine Lake Pharma Co. Ltd.
Guangdong Sheng, China
Patent: 145
Dana-Farber Cancer Institute, Inc.
Massachusetts, United States
Patent: 117
Pennsylvania, United States
Patent: 113
Colorado, United States
Patent: 104
With the analysis among related 7,286 patents in last 5 years, we discover 277 new entrants. Wuhan Renfu Innovative Drug Research and Development Center Co., Ltd., China Pharmaceutical University, Shanghai Meiyue Biotechnology Dev Co Ltd are the most active new entrants in this area.
Wuhan Renfu Innovative Drug Research and Development Center Co., Ltd.
Hubei Sheng, China
Patent: 85
China Pharmaceutical University
Jiangsu Sheng, China
Patent: 51
Shanghai Meiyue Biotechnology Dev Co Ltd
Shanghai Shi, China
Patent: 33
Aichi-ken, Japan
Patent: 26
Shanghai Huiqi Biomedical Technology Co., Ltd.
Hinova Pharmaceuticals, Inc.
Sichuan Sheng, China
Patent: 24
Fujian Cosunter Pharmaceutical Co., Ltd.
Fujian Sheng, China
Patent: 22
The Shenzhen Institutes of Advanced Technology
Shanghai Shi, China
Patent: 22
Betta Pharmaceuticals Co., Ltd.
Zhejiang Sheng, China
Patent: 22
With the analysis among 2,113 patents, we discovered top 233 universities and scientific research institutions by total patent application. The European Molecular Biology Laboratory, Institute Of Cancer Research, University of British Columbia are dominant in this area. They take 18.60% of the total patent filing.
The European Molecular Biology Laboratory
Baden-Württemberg, Germany
Patent: 154
Institute Of Cancer Research
University of British Columbia
British Columbia, Canada
Patent: 82
Shanghai Institute of Materia Medica Chinese Academy of Sciences
Shanghai Shi, China
Patent: 53
China Pharmaceutical University
Jiangsu Sheng, China
Patent: 51
Basel-Stadt, Switzerland
Patent: 47
Massachusetts Institute of Technology
Massachusetts, United States
Patent: 38
President & Fellows of Harvard College
Massachusetts, United States
Patent: 38
Ocean University of China
Shandong Sheng, China
Patent: 31
Beijing Shi, China
Patent: 28